Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more USWM CT, LLC 71
Early research (Phase 1)Study completedNCT02315066What this trial is testingStudy Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566Who this might be right forNeoplasms Pfizer 174
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Testing effectiveness (Phase 2)Ended earlyNCT04524689What this trial is testingTusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLCWho this might be right forNon-squamous Non-small-cell Lung Cancer (NSQ NSCLC) Sanofi 57
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT03950674What this trial is testingStudy of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension StudyWho this might be right forNon-Small-Cell Lung Carcinoma Merck Sharp & Dohme LLC 40
Large-scale testing (Phase 3)Study completedNCT01642004What this trial is testingStudy of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)Who this might be right forSquamous Cell Non-small Cell Lung Cancer Bristol-Myers Squibb 272
Not applicableApproved For MarketingNCT00684385What this trial is testingAn Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and NeckWho this might be right forNon Small Cell Lung CancerCancer of the Head and Neck AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT00799240What this trial is testingMK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung CancerWho this might be right forNon Small Cell Lung Cancer University of Kansas 27
Large-scale testing (Phase 3)Study completedNCT00028938What this trial is testingChemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerWho this might be right forLung Cancer Wake Forest University Health Sciences 1
Early research (Phase 1)Ended earlyNCT01249443What this trial is testingPaclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionWho this might be right forHIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more AIDS Malignancy Consortium 17
Early research (Phase 1)Study completedNCT03761017What this trial is testingMGD019 DART® Protein in Unresectable/Metastatic CancerWho this might be right forSquamous Cell Non Small Cell Lung CancerProstate Cancer MetastaticCutaneous Melanoma+3 more MacroGenics 162
Early research (Phase 1)Active Not RecruitingNCT05239143What this trial is testingP-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsWho this might be right forBreast CancerOvarian CancerNon Small Cell Lung Cancer+6 more Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)Looking for participantsNCT04136535What this trial is testingPemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLCWho this might be right forNSCLC Stage IV Fudan University 105
Testing effectiveness (Phase 2)Looking for participantsNCT05937906What this trial is testingClinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.Who this might be right forNon-Small Cell Lung Cancer Centre Georges Francois Leclerc 24
Large-scale testing (Phase 3)Study completedNCT01107626What this trial is testingBevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung CancerWho this might be right forLung Cancer ECOG-ACRIN Cancer Research Group 1,516
Large-scale testing (Phase 3)Study completedNCT05318443What this trial is testingA Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung CancerWho this might be right forNon-squamous Non-small-cell Lung Cancer Shanghai Institute Of Biological Products 512
Testing effectiveness (Phase 2)Ended earlyNCT00334763What this trial is testingRadiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Northwestern University 32
Testing effectiveness (Phase 2)Study completedNCT00979212What this trial is testingChemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung CancerWho this might be right forLung Cancer Radiation Therapy Oncology Group 71
Large-scale testing (Phase 3)Study completedNCT03409614What this trial is testingCombinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung CancerWho this might be right forNon-small Cell Lung Cancer Regeneron Pharmaceuticals 789